Psyence Biomedical Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	7.15	6.14	0.73	1.33	1.75
Cash & Short-Term Investments	7.15	6.14	0.73	1.33	1.75
Cash Growth	269.98%	736.78%	-45.05%	-23.91%	-
Other Receivables	0.17	0.14	0.04	0.15	0.04
Total Trade Receivables	0.17	0.14	0.04	0.15	0.04
Other Current Assets	0.31	0.29	0.35	0.11	0.04
Total Current Assets	7.63	6.56	1.13	1.59	1.83
Net Property, Plant & Equipment	0.01	0.01	0.01	-	-
Long-Term Investments	5.17	0.75	-	-	-
Total Assets	12.81	7.32	1.13	1.59	1.83
Accounts Payable	0.64	0.39	3.55	1.79	0.13
Short-Term Debt	-	-	7.66	-	-
Other Current Liabilities	0.3	0.2	0.9	-	-
Total Current Liabilities	0.94	0.59	12.1	1.79	0.13
Total Liabilities	0.94	0.59	12.1	1.79	0.13
Common Stock	68.88	61.75	46.13	5.93	4.54
Additional Paid-in Capital	1.42	1.42	0.36	0.17	0.26
Retained Earnings	-58.44	-56.45	-57.46	-6.3	-3.09
Shareholders' Equity	11.87	6.72	-10.97	-0.2	1.7
Total Liabilities & Equity	12.81	7.32	1.13	1.59	1.83
Total Debt	-	0	7.66	0	0
Net Cash (Debt)	7.15	6.14	-6.92	1.33	1.75
Net Cash Growth	16.54%	-	-	-23.91%	-
Net Cash Per Share	63.09	198.63	-3969.21	996.92	-
Book Value	11.87	6.72	-10.97	-0.2	1.7
Book Value Per Share	104.72	217.63	-6289.86	-149.76	-
Tangible Book Value	11.87	6.72	-10.97	-0.2	1.7
Tangible Book Value Per Share	104.72	217.63	-6289.86	-149.76	-

Updated Nov 20, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q